Common drug may hold key to faster ACL surgery recovery
NCT ID NCT07332910
Summary
This study is testing if a single dose of a medication called tranexamic acid (TXA) can reduce swelling and inflammation after ACL reconstruction surgery. Researchers will compare TXA to a placebo in 60 adults having this knee surgery to see if it helps control bleeding in the joint and improves early recovery. The main goal is to understand if TXA lowers markers of inflammation in the blood after surgery.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACL RECONSTRUCTION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Email: •••••@•••••
Locations
-
Chirec Delta
Brussels, 1160, Belgium
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact
Contact Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.